Aadi Bioscience Inc - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
AADI Nasdaq 2834 https://aadibio.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Aadi Bioscience Inc

Aadi Bioscience Reports Financial Results for the Third Quarter 2023 and Provides Corporate Update - Nov 8th, 2023 1:00 pm
Aadi Bioscience to Participate in Jefferies London Healthcare Conference - Nov 6th, 2023 9:05 pm
Aadi Bioscience to Report Third Quarter 2023 Results and Operational Update - Nov 1st, 2023 8:05 pm
Aadi Bioscience Announces Poster Presentations on Nab-Sirolimus at the International Gynecologic Cancer Society (IGCS) 2023 Annual Global Meeting - Oct 19th, 2023 8:05 pm
Aadi Bioscience Announces Poster Presentations at 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics - Oct 12th, 2023 8:05 pm
Aadi Bioscience Announces Poster Presentations at the North American Neuroendocrine Tumor Society (NANETS) 2023 Multidisciplinary NET Medical Symposium - Oct 5th, 2023 8:05 pm
Aadi Bioscience Grants New CEO Dave Lennon, Ph.D. Inducement Award Under Nasdaq Listing Rule 5635 (c)(4) - Oct 3rd, 2023 8:05 pm
Aadi Bioscience Appoints Dave Lennon, Ph.D. as President and Chief Executive Officer - Oct 2nd, 2023 12:00 pm
Aadi Bioscience to Participate at Upcoming Investor Conferences - Sep 5th, 2023 12:00 pm
Aadi Bioscience Announces Financial Results for the Second Quarter 2023 and Provides Corporate Update - Aug 9th, 2023 12:00 pm
Aadi Bioscience to Report Second Quarter 2023 Results and Operational Update - Aug 2nd, 2023 12:00 pm
Aadi Bioscience Announces Presentations at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting - May 25th, 2023 9:30 pm
Aadi Bioscience to Participate in Upcoming Investor Events - May 23rd, 2023 12:00 pm
Aadi Bioscience Announces Financial Results and Operational Update for the First Quarter 2023 and Provides Update on PRECISION 1 Tumor Agnostic Trial - May 10th, 2023 12:00 pm
Aadi Bioscience to Report First Quarter 2023 Results and Operational Update - May 3rd, 2023 12:00 pm
Aadi Bioscience Announces Multiple Presentations on nab-Sirolimus at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting - Apr 26th, 2023 8:05 pm
Aadi Bioscience to Present Multiple Posters on nab-Sirolimus at the 2023 American Association for Cancer Research (AACR) Annual Meeting - Apr 14th, 2023 5:00 pm
Aadi Bioscience to Present Multiple Posters at the American Association for Cancer Research (AACR) Annual Meeting 2023 - Apr 6th, 2023 8:30 pm
Aadi Bioscience Announces Financial Results for the Fourth Quarter and Full-Year 2022 and Provides Corporate Update - Mar 28th, 2023 12:00 pm
Aadi Bioscience Appoints Mohammad Hirmand, M.D. to Board of Directors - Mar 27th, 2023 12:00 pm